b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">31793555</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>08</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">1997-7298</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>119</Volume>\n                    <Issue>10</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova</Title>\n                <ISOAbbreviation>Zh Nevrol Psikhiatr Im S S Korsakova</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Comparative studies of neurotrophic drugs based on brain hydrolysates].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>134-140</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.17116/jnevro2019119101134</ELocationID>\n            <Abstract>\n                <AbstractText>The results of the analysis of comparative studies of neurotrophic drugs based on brain hydrolysates (BH) are presented. The most comprehensive comparative study of the BH drugs carried out by Zhang, et al. 2019 investigated the effects of four drugs (cognistar, cerebrolysate, cortexin, cerebrolysin) on a model of ischemic stroke in rats. The study showed that a significant improvement in the neurological outcome compared with placebo was observed only with cerebrolysin. Higher standardization in elemental composition, higher antioxidant activity, and presence of active peptide fragments of neuropeptides of nerve growth factor, enkephalins, orexin and galanin in cerebrolysin explains neurotrophic and neuroprotective effects of the drug.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Gromova</LastName>\n                    <ForeName>O A</ForeName>\n                    <Initials>OA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Federal Research Center \'Computer Science and Control\' of the Russian Academy of Sciences, Moscow, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Torshin</LastName>\n                    <ForeName>I Yu</ForeName>\n                    <Initials>IY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Federal Research Center \'Computer Science and Control\' of the Russian Academy of Sciences, Moscow, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stakhovskaia</LastName>\n                    <ForeName>L V</ForeName>\n                    <Initials>LV</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Maiorova</LastName>\n                    <ForeName>L A</ForeName>\n                    <Initials>LA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Macroheterocyclic Compounds, Ivanovo State University of Chemistry and Technology, 153000 Ivanovo, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ostrenko</LastName>\n                    <ForeName>K S</ForeName>\n                    <Initials>KS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Macroheterocyclic Compounds, Ivanovo State University of Chemistry and Technology, 153000 Ivanovo, Russia; Russian Research Institute of Physiology, Biochemistry and Animal Nutrition, Borovsk, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>rus</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <VernacularTitle>O sravnitel\'nykh \xc3\xa9ksperimental\'nykh issledovaniiakh ne\xc4\xadrotroficheskikh preparatov na osnove gidrolizatov golovnogo mozga.</VernacularTitle>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Russia (Federation)</Country>\n            <MedlineTA>Zh Nevrol Psikhiatr Im S S Korsakova</MedlineTA>\n            <NlmUniqueID>9712194</NlmUniqueID>\n            <ISSNLinking>1997-7298</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>88813-36-9</RegistryNumber>\n                <NameOfSubstance UI="D019004">Galanin</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019004" MajorTopicYN="N">Galanin</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018696" MajorTopicYN="Y">Neuroprotective Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <OtherAbstract Type="Publisher" Language="rus">\n            <AbstractText>\xd0\x9f\xd1\x80\xd0\xb5\xd0\xb4\xd1\x81\xd1\x82\xd0\xb0\xd0\xb2\xd0\xbb\xd0\xb5\xd0\xbd\xd1\x8b \xd1\x80\xd0\xb5\xd0\xb7\xd1\x83\xd0\xbb\xd1\x8c\xd1\x82\xd0\xb0\xd1\x82\xd1\x8b \xd0\xb0\xd0\xbd\xd0\xb0\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb0 \xd1\x81\xd1\x80\xd0\xb0\xd0\xb2\xd0\xbd\xd0\xb8\xd1\x82\xd0\xb5\xd0\xbb\xd1\x8c\xd0\xbd\xd1\x8b\xd1\x85 \xd0\xb8\xd1\x81\xd1\x81\xd0\xbb\xd0\xb5\xd0\xb4\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbd\xd0\xb8\xd0\xb9 \xd0\xbd\xd0\xb5\xd0\xb9\xd1\x80\xd0\xbe\xd1\x82\xd1\x80\xd0\xbe\xd1\x84\xd0\xb8\xd1\x87\xd0\xb5\xd1\x81\xd0\xba\xd0\xb8\xd1\x85 \xd0\xbf\xd1\x80\xd0\xb5\xd0\xbf\xd0\xb0\xd1\x80\xd0\xb0\xd1\x82\xd0\xbe\xd0\xb2 \xd0\xbd\xd0\xb0 \xd0\xbe\xd1\x81\xd0\xbd\xd0\xbe\xd0\xb2\xd0\xb5 \xd0\xb3\xd0\xb8\xd0\xb4\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb0\xd1\x82\xd0\xbe\xd0\xb2 \xd0\xb3\xd0\xbe\xd0\xbb\xd0\xbe\xd0\xb2\xd0\xbd\xd0\xbe\xd0\xb3\xd0\xbe \xd0\xbc\xd0\xbe\xd0\xb7\xd0\xb3\xd0\xb0. \xd0\x9d\xd0\xb0\xd0\xb8\xd0\xb1\xd0\xbe\xd0\xbb\xd0\xb5\xd0\xb5 \xd0\xbf\xd0\xbe\xd0\xbb\xd0\xbd\xd1\x8b\xd0\xbc \xd1\x81\xd1\x80\xd0\xb0\xd0\xb2\xd0\xbd\xd0\xb8\xd1\x82\xd0\xb5\xd0\xbb\xd1\x8c\xd0\xbd\xd1\x8b\xd0\xbc \xd0\xb8\xd1\x81\xd1\x81\xd0\xbb\xd0\xb5\xd0\xb4\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbd\xd0\xb8\xd0\xb5\xd0\xbc \xd0\xbf\xd1\x80\xd0\xb5\xd0\xbf\xd0\xb0\xd1\x80\xd0\xb0\xd1\x82\xd0\xbe\xd0\xb2 \xd0\xb3\xd0\xb8\xd0\xb4\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb0\xd1\x82\xd0\xbe\xd0\xb2 \xd0\xb3\xd0\xbe\xd0\xbb\xd0\xbe\xd0\xb2\xd0\xbd\xd0\xbe\xd0\xb3\xd0\xbe \xd0\xbc\xd0\xbe\xd0\xb7\xd0\xb3\xd0\xb0 \xd1\x8f\xd0\xb2\xd0\xbb\xd1\x8f\xd0\xb5\xd1\x82\xd1\x81\xd1\x8f \xd1\x80\xd0\xb0\xd0\xb1\xd0\xbe\xd1\x82\xd0\xb0 (Zhang, 2019), \xd0\xb2 \xd0\xba\xd0\xbe\xd1\x82\xd0\xbe\xd1\x80\xd0\xbe\xd0\xb9 \xd0\xb8\xd1\x81\xd1\x81\xd0\xbb\xd0\xb5\xd0\xb4\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbd\xd1\x8b \xd1\x8d\xd1\x84\xd1\x84\xd0\xb5\xd0\xba\xd1\x82\xd1\x8b \xd1\x87\xd0\xb5\xd1\x82\xd1\x8b\xd1\x80\xd0\xb5\xd1\x85 \xd0\xbb\xd0\xb5\xd0\xba\xd0\xb0\xd1\x80\xd1\x81\xd1\x82\xd0\xb2\xd0\xb5\xd0\xbd\xd0\xbd\xd1\x8b\xd1\x85 \xd0\xbf\xd1\x80\xd0\xb5\xd0\xbf\xd0\xb0\xd1\x80\xd0\xb0\xd1\x82\xd0\xbe\xd0\xb2 (\xd0\x9b\xd0\x9f) - \xd0\x9a\xd0\xbe\xd0\xb3\xd0\xbd\xd0\xb8\xd1\x81\xd1\x82\xd0\xb0\xd1\x80, \xd0\xa6\xd0\xb5\xd1\x80\xd0\xb5\xd0\xb1\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb0\xd1\x82, \xd0\x9a\xd0\xbe\xd1\x80\xd1\x82\xd0\xb5\xd0\xba\xd1\x81\xd0\xb8\xd0\xbd, \xd0\xa6\xd0\xb5\xd1\x80\xd0\xb5\xd0\xb1\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb8\xd0\xbd - \xd0\xbd\xd0\xb0 \xd0\xbc\xd0\xbe\xd0\xb4\xd0\xb5\xd0\xbb\xd0\xb8 \xd0\xb8\xd1\x88\xd0\xb5\xd0\xbc\xd0\xb8\xd1\x87\xd0\xb5\xd1\x81\xd0\xba\xd0\xbe\xd0\xb3\xd0\xbe \xd0\xb8\xd0\xbd\xd1\x81\xd1\x83\xd0\xbb\xd1\x8c\xd1\x82\xd0\xb0 \xd1\x83 \xd0\xba\xd1\x80\xd1\x8b\xd1\x81. \xd0\xa0\xd0\xb5\xd0\xb7\xd1\x83\xd0\xbb\xd1\x8c\xd1\x82\xd0\xb0\xd1\x82\xd1\x8b \xd0\xb8\xd1\x81\xd1\x81\xd0\xbb\xd0\xb5\xd0\xb4\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbd\xd0\xb8\xd1\x8f \xd0\xbf\xd1\x80\xd0\xbe\xd0\xb4\xd0\xb5\xd0\xbc\xd0\xbe\xd0\xbd\xd1\x81\xd1\x82\xd1\x80\xd0\xb8\xd1\x80\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbb\xd0\xb8, \xd1\x87\xd1\x82\xd0\xbe \xd0\xb7\xd0\xbd\xd0\xb0\xd1\x87\xd0\xb8\xd1\x82\xd0\xb5\xd0\xbb\xd1\x8c\xd0\xbd\xd0\xbe\xd0\xb5 \xd1\x83\xd0\xbb\xd1\x83\xd1\x87\xd1\x88\xd0\xb5\xd0\xbd\xd0\xb8\xd0\xb5 \xd0\xbf\xd0\xbe\xd0\xba\xd0\xb0\xd0\xb7\xd0\xb0\xd1\x82\xd0\xb5\xd0\xbb\xd0\xb5\xd0\xb9 \xd0\xbd\xd0\xb5\xd0\xb2\xd1\x80\xd0\xbe\xd0\xbb\xd0\xbe\xd0\xb3\xd0\xb8\xd1\x87\xd0\xb5\xd1\x81\xd0\xba\xd0\xbe\xd0\xb3\xd0\xbe \xd0\xb8\xd1\x81\xd1\x85\xd0\xbe\xd0\xb4\xd0\xb0 \xd0\xbf\xd0\xbe \xd1\x81\xd1\x80\xd0\xb0\xd0\xb2\xd0\xbd\xd0\xb5\xd0\xbd\xd0\xb8\xd1\x8e \xd1\x81 \xd0\xbf\xd0\xbb\xd0\xb0\xd1\x86\xd0\xb5\xd0\xb1\xd0\xbe \xd0\xbe\xd1\x82\xd0\xbc\xd0\xb5\xd1\x87\xd0\xb5\xd0\xbd\xd0\xbe \xd1\x82\xd0\xbe\xd0\xbb\xd1\x8c\xd0\xba\xd0\xbe \xd0\xbf\xd1\x80\xd0\xb8 \xd0\xb8\xd1\x81\xd0\xbf\xd0\xbe\xd0\xbb\xd1\x8c\xd0\xb7\xd0\xbe\xd0\xb2\xd0\xb0\xd0\xbd\xd0\xb8\xd0\xb8 \xd0\x9b\xd0\x9f \xd0\xa6\xd0\xb5\xd1\x80\xd0\xb5\xd0\xb1\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb8\xd0\xbd. \xd0\x91\xd0\xbe\xd0\xbb\xd0\xb5\xd0\xb5 \xd0\xb2\xd1\x8b\xd1\x81\xd0\xbe\xd0\xba\xd0\xb0\xd1\x8f \xd1\x81\xd1\x82\xd0\xb0\xd0\xbd\xd0\xb4\xd0\xb0\xd1\x80\xd1\x82\xd0\xb8\xd0\xb7\xd0\xb0\xd1\x86\xd0\xb8\xd1\x8f \xd0\xbf\xd0\xbe \xd1\x8d\xd0\xbb\xd0\xb5\xd0\xbc\xd0\xb5\xd0\xbd\xd1\x82\xd0\xbd\xd0\xbe\xd0\xbc\xd1\x83 \xd1\x81\xd0\xbe\xd1\x81\xd1\x82\xd0\xb0\xd0\xb2\xd1\x83, \xd0\xb1\xd0\xbe\xd0\xbb\xd0\xb5\xd0\xb5 \xd0\xb2\xd1\x8b\xd1\x81\xd0\xbe\xd0\xba\xd0\xb0\xd1\x8f \xd0\xb0\xd0\xbd\xd1\x82\xd0\xb8\xd0\xbe\xd0\xba\xd1\x81\xd0\xb8\xd0\xb4\xd0\xb0\xd0\xbd\xd1\x82\xd0\xbd\xd0\xb0\xd1\x8f \xd0\xb0\xd0\xba\xd1\x82\xd0\xb8\xd0\xb2\xd0\xbd\xd0\xbe\xd1\x81\xd1\x82\xd1\x8c \xd0\xb8 \xd0\xbd\xd0\xb0\xd0\xbb\xd0\xb8\xd1\x87\xd0\xb8\xd0\xb5 \xd0\xb0\xd0\xba\xd1\x82\xd0\xb8\xd0\xb2\xd0\xbd\xd1\x8b\xd1\x85 \xd0\xbf\xd0\xb5\xd0\xbf\xd1\x82\xd0\xb8\xd0\xb4\xd0\xbd\xd1\x8b\xd1\x85 \xd1\x84\xd1\x80\xd0\xb0\xd0\xb3\xd0\xbc\xd0\xb5\xd0\xbd\xd1\x82\xd0\xbe\xd0\xb2 \xd0\xbd\xd0\xb5\xd0\xb9\xd1\x80\xd0\xbe\xd0\xbf\xd0\xb5\xd0\xbf\xd1\x82\xd0\xb8\xd0\xb4\xd0\xbe\xd0\xb2 \xd1\x84\xd0\xb0\xd0\xba\xd1\x82\xd0\xbe\xd1\x80\xd0\xb0 \xd1\x80\xd0\xbe\xd1\x81\xd1\x82\xd0\xb0 \xd0\xbd\xd0\xb5\xd1\x80\xd0\xb2\xd0\xbe\xd0\xb2, \xd1\x8d\xd0\xbd\xd0\xba\xd0\xb5\xd1\x84\xd0\xb0\xd0\xbb\xd0\xb8\xd0\xbd\xd0\xbe\xd0\xb2, \xd0\xbe\xd1\x80\xd0\xb5\xd0\xba\xd1\x81\xd0\xb8\xd0\xbd\xd0\xb0, \xd0\xb3\xd0\xb0\xd0\xbb\xd0\xb0\xd0\xbd\xd0\xb8\xd0\xbd\xd0\xb0 \xd0\xb2 \xd1\x81\xd0\xbe\xd1\x81\xd1\x82\xd0\xb0\xd0\xb2\xd0\xb5 \xd0\x9b\xd0\x9f \xd0\xa6\xd0\xb5\xd1\x80\xd0\xb5\xd0\xb1\xd1\x80\xd0\xbe\xd0\xbb\xd0\xb8\xd0\xb7\xd0\xb8\xd0\xbd \xd0\xbe\xd0\xb1\xd1\x8a\xd1\x8f\xd1\x81\xd0\xbd\xd1\x8f\xd1\x8e\xd1\x82 \xd0\xb5\xd0\xb3\xd0\xbe \xd0\xbd\xd0\xb5\xd0\xb9\xd1\x80\xd0\xbe\xd1\x82\xd1\x80\xd0\xbe\xd1\x84\xd0\xb8\xd1\x87\xd0\xb5\xd1\x81\xd0\xba\xd0\xbe\xd0\xb5 \xd0\xb8 \xd0\xbd\xd0\xb5\xd0\xb9\xd1\x80\xd0\xbe\xd0\xbf\xd1\x80\xd0\xbe\xd1\x82\xd0\xb5\xd0\xba\xd1\x82\xd0\xbe\xd1\x80\xd0\xbd\xd0\xbe\xd0\xb5 \xd0\xb4\xd0\xb5\xd0\xb9\xd1\x81\xd1\x82\xd0\xb2\xd0\xb8\xd0\xb5.</AbstractText>\n        </OtherAbstract>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">cerebrolysin</Keyword>\n            <Keyword MajorTopicYN="N">neuropeptides</Keyword>\n            <Keyword MajorTopicYN="N">neuroprotection</Keyword>\n            <Keyword MajorTopicYN="N">proteomics</Keyword>\n            <Keyword MajorTopicYN="N">standardization of composition</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31793555</ArticleId>\n            <ArticleId IdType="doi">10.17116/jnevro2019119101134</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'